Literature DB >> 9590503

Hemopoiesis in long-term stroma-dependent cultures from lymphoid tissue: production of cells with myeloid/dendritic characteristics.

K Ni1, H C O'Neill.   

Abstract

A long-term stroma-dependent culture system (LTC) has been developed which continuously produces hemopoietic cells providing an in vitro system for the study of cell differentiation. These nonadherent cell populations contain a large subpopulation of dendritic cells (DC). LTC producing DC were easily generated from spleen, but could also be established from bone marrow (BM) and lymph node with less success. It was difficult to establish DC-producing LTC from thymus. The properties of splenic and thymic stroma have been compared. Spleen stroma developed more complicated networks of fibroblasts, endothelial cells, macrophages, and DC. Thymic stromal monolayers were dominated by epithelial cells and fibroblasts, with a lower proportion of macrophages and endothelial cells. They had a relatively sparse structure of cell networks compared with spleen stroma. Cells with dendritiform morphology first appeared in cultures by 2-3 wk. The majority of cells produced were large cells which expressed DC-specific cell surface markers, major histocompatibility complex (MHC) Class II molecules, and the CD80/CD86(B7) costimulator. A high proportion of cells also expressed myeloid cell markers. No T or B lymphoid cells or granulocytes were present in the cultures. LTC continued to produce nonadherent cells resembling myeloid/DC for long periods, even after passage of stromal cells and stem cells at about 3-4 mo. after culture establishment. The LTC system offers potential to study the in vitro differentiation of myeloid/DC.

Entities:  

Mesh:

Year:  1998        PMID: 9590503     DOI: 10.1007/s11626-998-0006-0

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  65 in total

1.  Dendritic accessory cells derived from rat bone marrow precursors under chemically defined conditions in vitro belong to the myeloid lineage.

Authors:  R K Gieseler; R A Röber; R Kuhn; K Weber; M Osborn; J H Peters
Journal:  Eur J Cell Biol       Date:  1991-02       Impact factor: 4.492

2.  Stimulation of differentiation and proliferation of haemopoietic cells in vitro.

Authors:  T M Dexter; T D Allen; L G Lajtha; R Schofield; B I Lord
Journal:  J Cell Physiol       Date:  1973-12       Impact factor: 6.384

3.  Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues.

Authors:  I S Trowbridge; J Lesley; R Schulte; R Hyman; J Trotter
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

4.  A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology.

Authors:  J Obeso; J Weber; R Auerbach
Journal:  Lab Invest       Date:  1990-08       Impact factor: 5.662

5.  Cloning of a thymic stromal cell capable of protecting thymocytes from apoptosis.

Authors:  J G Amarante-Mendes; R Chammas; P Abrahamsohn; P C Patel; E F Potworowski; M S Macedo
Journal:  Cell Immunol       Date:  1995-04-01       Impact factor: 4.868

6.  Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses.

Authors:  L Lu; M Hsieh; T B Oriss; P A Morel; T E Starzl; A S Rao; A W Thomson
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

7.  Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.

Authors:  H C O'Neill; K Ni
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

8.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Authors:  P S Linsley; W Brady; L Grosmaire; A Aruffo; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

9.  Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells.

Authors:  D D Wagner; J B Olmsted; V J Marder
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

10.  The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs.

Authors:  D A Hume; A P Robinson; G G MacPherson; S Gordon
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  6 in total

1.  Identification of progenitor cells in long-term spleen stromal cultures that produce immature dendritic cells.

Authors:  H L Wilson; K Ni; H C O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Heterogeneity amongst splenic stromal cell lines which support dendritic cell hematopoiesis.

Authors:  Geneviève Despars; Helen C O'Neill
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

3.  Delineation of a novel dendritic-like subset in human spleen.

Authors:  Sawang Petvises; Dipti Talaulikar; Helen C O'Neill
Journal:  Cell Mol Immunol       Date:  2015-04-20       Impact factor: 11.530

4.  Extramedullary hematopoiesis: mesenchymal stromal cells from spleen provide an in vitro niche for myelopoiesis.

Authors:  Sawang Petvises; Vinson Tran; Ying-Ying Hey; Dipti Talaulikar; Terence J O'Neill; Jonathan Tan; Helen C O'Neill
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-05-31       Impact factor: 2.723

5.  Persistent propagation of variant Creutzfeldt-Jakob disease agent in murine spleen stromal cell culture with features of mesenchymal stem cells.

Authors:  Sergey Akimov; Oksana Yakovleva; Irina Vasilyeva; Carroll McKenzie; Larisa Cervenakova
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

6.  Myelopoiesis in spleen-producing distinct dendritic-like cells.

Authors:  Jonathan K H Tan; Helen C O'Neill
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.